Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$49.3K Hold
1,763
0.04% 156
2024
Q1
$48.9K Sell
1,763
-1,458
-45% -$40.5K 0.04% 155
2023
Q4
$92.7K Sell
3,221
-3,860
-55% -$117K 0.09% 127
2023
Q3
$235K Hold
7,081
0.22% 83
2023
Q2
$260K Hold
7,081
0.24% 80
2023
Q1
$289K Hold
7,081
0.27% 69
2022
Q4
$363K Sell
7,081
-8,200
-54% -$393K 0.36% 60
2022
Q3
$669K Hold
15,281
0.64% 44
2022
Q2
$801K Hold
15,281
0.81% 35
2022
Q1
$791K Hold
15,281
0.72% 33
2021
Q4
$902K Sell
15,281
-1,200
-7% -$59.5K 0.8% 34
2021
Q3
$709K Buy
16,481
+4,000
+32% +$177K 0.63% 39
2021
Q2
$489K Buy
+12,481
New +$485K 0.43% 54

Other funds holding PFE

EMFO LLC's PFE Position: Q2 2024 in Review

EMFO LLC held its Pfizer (PFE) position steady in Q2 2024 at 1,763 shares worth $49.3K. The position accounts for 0.04% of the portfolio, ranked #156.

EMFO LLC first reported a position in PFE in Q2 2021 and has held it in 13 quarters since. The position peaked at $902K in Q4 2021. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • EMFO LLC held 1,763 shares of Pfizer worth $49.3K as of Q2 2024.
  • EMFO LLC left its Pfizer share count unchanged in Q2 2024.
  • Pfizer made up 0.04% of EMFO LLC's portfolio in Q2 2024, its #156 holding.
  • EMFO LLC first reported a position in Pfizer in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's Pfizer position peaked at $902K in Q4 2021.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.